157 related articles for article (PubMed ID: 33991221)
1. Effect of vaginal estrogen in postmenopausal women using vaginal pessary for pelvic organ prolapse treatment: a randomized controlled trial.
Chiengthong K; Ruanphoo P; Chatsuwan T; Bunyavejchevin S
Int Urogynecol J; 2022 Jul; 33(7):1833-1838. PubMed ID: 33991221
[TBL] [Abstract][Full Text] [Related]
2. Does vaginal estrogen treatment with support pessaries in vaginal prolapse reduce complications?
Bulchandani S; Toozs-Hobson P; Verghese T; Latthe P
Post Reprod Health; 2015 Dec; 21(4):141-5. PubMed ID: 26537626
[TBL] [Abstract][Full Text] [Related]
3. Effect of vaginal estrogen on pessary use.
Dessie SG; Armstrong K; Modest AM; Hacker MR; Hota LS
Int Urogynecol J; 2016 Sep; 27(9):1423-9. PubMed ID: 26992727
[TBL] [Abstract][Full Text] [Related]
4. Pessaries (mechanical devices) for managing pelvic organ prolapse in women.
Bugge C; Adams EJ; Gopinath D; Stewart F; Dembinsky M; Sobiesuo P; Kearney R
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD004010. PubMed ID: 33207004
[TBL] [Abstract][Full Text] [Related]
5. Effect of estrogen on vaginal complications of pessary use: a systematic review and meta-analysis.
Ai F; Wang Y; Wang J; Zhou L; Wang S
Climacteric; 2022 Dec; 25(6):533-542. PubMed ID: 35695119
[TBL] [Abstract][Full Text] [Related]
6. ESTROgen use for complications in women treating pelvic organ prolapse with vaginal PESSaries (ESTRO-PESS)-a randomized clinical trial.
de Albuquerque Coelho SC; Giraldo PC; Brito LGO; Juliato CRT
Int Urogynecol J; 2021 Jun; 32(6):1571-1578. PubMed ID: 33501563
[TBL] [Abstract][Full Text] [Related]
7. Vaginal Pessary in Women With Symptomatic Pelvic Organ Prolapse: A Randomized Controlled Trial.
Cheung RY; Lee JH; Lee LL; Chung TK; Chan SS
Obstet Gynecol; 2016 Jul; 128(1):73-80. PubMed ID: 27275798
[TBL] [Abstract][Full Text] [Related]
8. An Arterial Vaginal Bleed Resulting from Short-Term Pessary Use: A Case Report.
Rieben K; Epp A
J Obstet Gynaecol Can; 2021 Apr; 43(4):503-505. PubMed ID: 33153940
[TBL] [Abstract][Full Text] [Related]
9. Effects of pelvic organ prolapse ring pessary therapy on intravaginal microbial flora.
Yoshimura K; Morotomi N; Fukuda K; Hachisuga T; Taniguchi H
Int Urogynecol J; 2016 Feb; 27(2):219-27. PubMed ID: 26377332
[TBL] [Abstract][Full Text] [Related]
10. Effect of Local Estrogen Cream on Vaginal Health after Pessary Use for Prolapsed Pelvic Organ: A Randomized Controlled Trial.
Tontivuthikul P; Sanmee U; Wongtra-Ngan S; Pongnarisorn C
J Med Assoc Thai; 2016 Jul; 99(7):757-63. PubMed ID: 29901374
[TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial comparing internal and external pessaries in the treatment of pelvic organ prolapse in postmenopausal women: A pilot study.
Hosoume RS; Peterson TV; Soares Júnior JM; Baracat EC; Haddad JM
Clinics (Sao Paulo); 2024; 79():100335. PubMed ID: 38484583
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of a continuous-use ring-shaped vaginal pessary without support for advanced pelvic organ prolapse in postmenopausal women.
Dueñas JL; Miceli A
Int Urogynecol J; 2018 Nov; 29(11):1629-1636. PubMed ID: 29478114
[TBL] [Abstract][Full Text] [Related]
13. Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse.
Yimphong T; Temtanakitpaisan T; Buppasiri P; Chongsomchai C; Kanchaiyaphum S
Int Urogynecol J; 2018 Aug; 29(8):1123-1128. PubMed ID: 28815277
[TBL] [Abstract][Full Text] [Related]
14. Changes in the Vaginal Microenvironment as Related to Frequency of Pessary Removal.
Fregosi NJ; Hobson DTG; Kinman CL; Gaskins JT; Stewart JR; Meriwether KV
Female Pelvic Med Reconstr Surg; 2018; 24(2):166-171. PubMed ID: 29474292
[TBL] [Abstract][Full Text] [Related]
15. A tailored flexible vaginal pessary treatment for pelvic organ prolapse in older women.
Gold RS; Baruch Y; Amir H; Gordon D; Groutz A
J Am Geriatr Soc; 2021 Sep; 69(9):2518-2523. PubMed ID: 33979457
[TBL] [Abstract][Full Text] [Related]
16. Effect of Pessary vs Surgery on Patient-Reported Improvement in Patients With Symptomatic Pelvic Organ Prolapse: A Randomized Clinical Trial.
van der Vaart LR; Vollebregt A; Milani AL; Lagro-Janssen AL; Duijnhoven RG; Roovers JWR; van der Vaart CH
JAMA; 2022 Dec; 328(23):2312-2323. PubMed ID: 36538310
[TBL] [Abstract][Full Text] [Related]
17. Vaginal Pessaries for Pelvic Organ Prolapse or Stress Urinary Incontinence: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(3):1-155. PubMed ID: 34055111
[TBL] [Abstract][Full Text] [Related]
18. An estriol-eluting pessary to treat pelvic organ prolapse.
Long J; Zidan G; Seyfoddin A; Tong S; Brownfoot FC; Chowdary P
Sci Rep; 2022 Nov; 12(1):20021. PubMed ID: 36414726
[TBL] [Abstract][Full Text] [Related]
19. Changes of intravaginal microbiota and inflammation after self-replacement ring pessary therapy compared to continuous ring pessary usage for pelvic organ prolapse.
Yoshimura K; Morotomi N; Fukuda K; Kubo T; Taniguchi H
J Obstet Gynaecol Res; 2020 Jun; 46(6):931-938. PubMed ID: 32189434
[TBL] [Abstract][Full Text] [Related]
20. Predictors for dislodgment of vaginal pessary within one year in women with pelvic organ prolapse.
Cheung RYK; Lee LLL; Chung TKH; Chan SSC
Maturitas; 2018 Feb; 108():53-57. PubMed ID: 29290215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
